Article
Large contribution of copy number alterations in early stage of Papillary Thyroid Carcinoma.
Computers in biology and medicine - 1 Aug 2021
Hosseinkhan Nazanin, Honardoost Maryam, Blighe Kevin, Moore Tara, Khamseh Mohammad E
Abstract excerpt
Papillary Thyroid Carcinoma (PTC) accounts for approximately 85% of patients with thyroid cancer. Despite its indolent nature, progression to higher stages is expected in a subgroup of patients. Hence, genomic characterization of the early stages of PTC may help to identify this subgroup, leading to better clinical management. Here, we conducted a comprehensive mutational and somatic copy number alteration (SCNA)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
